We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Researchers Develop Stem Cell Therapies for Acute Lung Injury

An estimated 200,000 patients a year have acute respiratory failure in the U.S. and mortality is about 30 to 40 percent.
News

Life Technologies Extends Partnership with DNAVEC

R&D collaborative agreement aims to further develop Sendai virus-based tools for basic and translational research.
News

Stem Cell Transplant Repairs Damaged Gut in Mouse Model of IBD

The findings pave the way for patient-specific regenerative therapies for inflammatory bowel diseases such as ulcerative colitis.
News

Stem Cell Therapeutics Acquires Complementary Antibody Program

The company has entered into an option agreement to exclusively license worldwide rights to a panel of fully human monoclonal antibodies targeting the SIRPa protein (CD172a).
News

Cellular Dynamics Issued U.S. Patent

The patent relates to the method by which induced pluripotent stem cells are differentiated into the diverse types of endothelial and hematopoietic cells.
News

Single Gene Mutation Linked to Neurological Disorders

Mutation could offer insights into Alzheimer’s, Parkinson’s and Huntigton’s Diseases.
News

Developing a Semantically Rich Ontology for the Biobank-Administration Domain

Recent research has provided compelling examples of using semantic web technologies, such as ontologies, to retrieve research-relevant data from biobanks.
News

Mayo Clinic Launches Biobank in Arizona, Expanding Diversity Research

Mayo Clinic biobank will support studies in obesity, metabolism and diabetes, all areas of special concern in the Latino population.
News

New Bio Bank to Resolve Legal and Ethical Issues

When researchers collect human tissue in a so-called bio bank, the purpose is usually to learn about various diseases and improve curing of them.
News

Improving Cord Blood Transplants

Researchers have published initial results of a Phase Ib human clinical trial of a therapeutic that could improve the success of blood stem cell transplantation.
Advertisement